A DNA-based computer is developed and commercialized. The claim is YES if such a machine is sold for more than $1 by the claim date.
Background: Report on DNA-based Computers Workshop by John Amenyo
Standard ambiguity clause: If the wording is found to be ambiguous I will judge on the basis of the obvious intent. If the intent is ambiguous I will judge on the basis of precise wording. If both are ambiguous or if both are clear but conflict, I will look for a solution that causes the least damage to FX as a market and game.
In particular, the development and commercialization of humans (cloned or otherwise) would not dictate a YES for this claim.